Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...

Kirk Perry has been named interim CEO, effective immediately, as the board conducts a search for Mongon's permanent successor ...

Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.

American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim ...

Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...

Kenvue, the Johnson & Johnson spinoff that owns brands such as Tylenol and Benadryl, announced Monday that Chief Executive ...

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...

Kenvue chief executive officer, Thibaut Mongon, has stepped down from the role and the company's board amid an ongoing ...

Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors is implementing a set of actions to enable the Company ...

Current Kenvue Director, Kirk Perry, is named Interim CEO, effective immediately. Kenvue Board of Directors appointed a new Interim CEO and is advancing an ongoing comprehensive review of strategic ...